Back to search
FDAFDA · Food and drugs·Recall number D-0543-2024

Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-8

Published June 12, 2024 · Recall initiated: May 16, 2024

Summary

FDA records drug Class III recall D-0543-2024, published June 12, 2024 and initiated May 16, 2024. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Ongoing; Reported quantity: 13,440 units; Lot: Lot #: M311202, Exp. Date 2/25; M311201, Exp. Date 1/25. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if ESTRADIOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ESTRADIOL
Manufacturer
Zydus Pharmaceuticals (USA) Inc
Distributor
Nationwide within the United States
UPC
0370710119188
Lot
Lot #: M311202, Exp. Date 2/25; M311201, Exp. Date 1/25
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-8 recalled?

Yes. FDA published recall D-0543-2024 on June 12, 2024. Reported hazard: Failed Impurities/Degradation Specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ESTRADIOL. UPC: 0370710119188.